Medtronic releases all-in-one device in Europe:
This article was originally published in Clinica
Executive Summary
Medtronic has announced the European commercial release of its device for fast and slow heart rhythms. The Medtronic Jewel AF is an implantable arrhythmia management device that has both detection and therapeutic capabilities. Medtronic claims that the Jewel AF is the world's first device to deliver tiered atrial therapies and pacing. It will first be indicated for patients who suffer fast ventricular arrhythmias. The device is still under clinical evaluation in the US.
You may also be interested in...
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.